Skip to main content
. 2021 May 29;21:642. doi: 10.1186/s12885-021-08032-y

Fig. 4.

Fig. 4

Mean changes from baseline on treatment for EORTC QLQ-C30 global health status. EORTC European Organisation for Research and Treatment of Cancer, IPI ipilimumab, QLQ-C30 Core Quality of Life Questionnaire, SE standard error